Publication:
Zoledronic acid with either standard or reduced dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: A phase IV randomized study.

Simple item page
dc.contributor.authorsAtahan, I. L.; Yildiz, F.; Cengiz, M.; Kaplan, B.; Ozkan, M.; Haydaroglu, A.; Sengoz, M.; Korcum, A. F.; Akmansu, M.; Engin, K.
dc.date.accessioned2022-03-12T15:59:40Z
dc.date.accessioned2026-01-10T17:41:47Z
dc.date.available2022-03-12T15:59:40Z
dc.date.issued2006
dc.identifier.doidoiWOS:000242719100381
dc.identifier.eissn1879-0887
dc.identifier.issn0167-8140
dc.identifier.urihttps://hdl.handle.net/11424/224474
dc.identifier.wosWOS:000242719100381
dc.language.isoeng
dc.publisherELSEVIER IRELAND LTD
dc.relation.ispartofRADIOTHERAPY AND ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleZoledronic acid with either standard or reduced dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: A phase IV randomized study.
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPageS151
oaire.citation.startPageS150
oaire.citation.titleRADIOTHERAPY AND ONCOLOGY
oaire.citation.volume81

Files

Collections

Araştırma Çıktıları